Tag: BioNTech

BioNTech SE has achieved a significant milestone in its oncology pipeline, with a novel breast cancer therapy demonstrating superior results ...

German biotechnology firm BioNTech has announced a significant advancement in its oncology pipeline, marking a pivotal achievement beyond its renowned ...

A significant regulatory milestone achieved by Mainz-based biotechnology firm BioNTech in late August has reignited investor optimism. The U.S. Food ...

BioNTech SE is executing a remarkable strategic transformation, evolving from its pandemic-era identity into a diversified biotechnology powerhouse. This shift ...

After a prolonged period of decline, investors in BioNTech SE may finally have reasons for optimism. A trio of significant ...

Shares of German biotech firm BioNTech SE came under intense pressure following concerning reports from the United States regarding a ...

BioNTech is executing a fundamental strategic realignment, moving decisively away from its pandemic-related business toward an intensified focus on cancer ...

The German biopharmaceutical company BioNTech SE has re-entered the spotlight following a prolonged period of sideways trading. A recent regulatory ...

BioNTech has achieved another significant regulatory milestone as Health Canada grants authorization for the biotech firm's latest COVID-19 vaccine formulation. ...

BioNTech delivered a mixed second-quarter performance in 2025, with revenues soaring to €261 million—more than double the previous year’s figure ...